Canopy Growth (CGC) Accumulated Expenses (2019 - 2025)
Canopy Growth's (CGC) quarterly Accumulated Expenses came in at $9.1 million in Q4 2025, up 17.43% year-on-year from $7.7 million in Q4 2024, and down 68.25% quarter-over-quarter from $28.7 million in Q3 2025.
Canopy Growth (CGC) Accumulated Expenses (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Accumulated Expenses across 7 years of filings, most recently posting $9.1 million for Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $9.1 million, up 17.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.1 million (up 17.43% YoY), and the FY2025 annual result was $9.6 million, down 39.94% from the prior year.
- Accumulated Expenses came in at $9.1 million for Q4 2025 at Canopy Growth, down from $28.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $68.4 million in Q3 2021 to a low of $7.7 million in Q4 2024.
- The 5-year median for Accumulated Expenses is $20.2 million (2022), against an average of $28.3 million.
- Across the five-year window, Accumulated Expenses surged 1277.91% in 2021 and slumped 77.5% in 2023, its largest moves.
- Canopy Growth's Accumulated Expenses stood at $17.9 million in 2021, then jumped by 212.78% to $56.0 million in 2022, then plunged by 77.5% to $12.6 million in 2023, then plunged by 38.49% to $7.7 million in 2024, then increased by 17.43% to $9.1 million in 2025.
- The last three Accumulated Expenses figures came in at $9.1 million (Q4 2025), $28.7 million (Q3 2025), and $11.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Canopy Growth | 11.16 Mn | -137.54 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.10 Mn |
| Sep 30, 2025 | 28.65 Mn |
| Jun 30, 2025 | 11.74 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 7.75 Mn |
| Sep 30, 2024 | 31.33 Mn |
| Jun 30, 2024 | 15.83 Mn |
| Mar 31, 2024 | 15.93 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 56.15 Mn |
| Mar 31, 2023 | 20.21 Mn |
| Dec 31, 2022 | 55.98 Mn |
| Sep 30, 2022 | 20.14 Mn |
| Jun 30, 2022 | 46.99 Mn |
| Mar 31, 2022 | 59.43 Mn |
| Dec 31, 2021 | 17.90 Mn |
| Sep 30, 2021 | 68.38 Mn |
| Jun 30, 2021 | 29.34 Mn |
| Mar 31, 2021 | 37.32 Mn |